19485411|t|Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
19485411|a|A novel strategy to develop site-activated multifunctional chelators for targeting multiple etiologies of Alzheimer's disease is reported. The novel prochelator HLA20A with improved cytotoxicity shows little affinity for metal ions until it is activated by binding and inhibiting acetylcholinesterase (AChE), releasing an active chelator HLA20 that modulates amyloid precursor protein (APP) regulation and beta-amyloid (Abeta) reduction, suppresses oxidative stress, and passivates excess metal ions (Fe, Cu, and Zn) in the brain.
19485411	45	65	acetylcholinesterase	Gene	43
19485411	116	127	Alzheimer's	Disease	MESH:D000544
19485411	243	262	Alzheimer's disease	Disease	MESH:D000544
19485411	319	331	cytotoxicity	Disease	MESH:D064420
19485411	417	437	acetylcholinesterase	Gene	43
19485411	439	443	AChE	Gene	43
19485411	475	480	HLA20	Chemical	MESH:C505060
19485411	496	521	amyloid precursor protein	Gene	351
19485411	557	562	Abeta	Gene	351
19485411	638	640	Fe	Chemical	MESH:D007501
19485411	642	644	Cu	Chemical	MESH:D003300
19485411	650	652	Zn	Chemical	MESH:D015032
19485411	Negative_Correlation	MESH:D064420	43
19485411	Positive_Correlation	MESH:C505060	MESH:D007501
19485411	Association	MESH:C505060	351
19485411	Positive_Correlation	MESH:C505060	MESH:D003300
19485411	Association	MESH:C505060	43
19485411	Positive_Correlation	MESH:C505060	MESH:D015032

